Drugs / PDI-192
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01826461 | Mar → Dec 2013 | atopic eczema | PreCision Dermatology, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PDI-192 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01826461 ↗ |
| Route | Topical | “topical foam, 0.1% concentration, twice daily” NCT01826461 ↗ |